Pure Global
PACTR202301820107782

Efficacy of autologous platelet rich plasma on morphea: A comparative clinical and ultrasonographic follow up study

Dermatology department·Not Applicable·Pan Africa Clinical Trials Registry·otherCompleted
Study focus
Disease/Condition
Skin and Connective Tissue Diseases
Intervention type
other
Sponsor & location
Primary sponsor
Dermatology department
Funder
Esraa Elnaquib
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
Jul 17, 2021
End date
Sep 30, 2021
Summary

Platelet-rich-plasma (PRP) is an effective treatment for skin atrophy with limited side effects. In this study we aimed to evaluate the efficacy and safety of PRP to restore skin changes in morphea such as ( skin atrophy, dyspigmentation and adnexal destruction) by ultrasound and Localized Scleroderma Cutaneous Assessment Tool (LoSCAT).

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202301820107782
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202301820107782 through Pure Global AI's free database. This Not Applicable trial is sponsored by Dermatology department and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.